Literature DB >> 11849471

Lecithinized superoxide dismutase reduces cold ischemia-induced chronic allograft dysfunction.

Ken Nakagawa1, Dicken D H Koo, David R Davies, Derek W R Gray, Andrew J McLaren, Kenneth I Welsh, Peter J Morris, Susan V Fuggle.   

Abstract

BACKGROUND: Chronic renal allograft failure (CAF) is influenced by both allo-dependent and independent factors and is a major cause of graft loss in clinical renal transplantation. We evaluated a novel membrane-bound free radical scavenger, lecithinized superoxide dismutase (lec-SOD), to determine its potential in limiting the harmful effects of ischemia/reperfusion injury on CAF.
METHODS: Fisher rat kidneys were stored for either 1 hour or 18 hours in cold Marshall's preservation solution either with or without lec-SOD and transplanted into Lewis recipients.
RESULTS: Within 3 days of transplantation, an early inflammatory response involving granulocytes and macrophages was detected in renal allografts exposed to 18 hours cold ischemia that was significantly reduced by preservation with lec-SOD. By 24 weeks post-transplantation, elevated proteinuria and detection of apoptotic cells was observed in kidneys exposed to 18 hours of cold ischemia, that was attenuated by preservation with lec-SOD (P < 0.05). However, up-regulated expression of intracellular adhesion molecule-1 (ICAM-1) and major histocompatibility complex (MHC) Class II together with a T lymphocyte infiltration were observed at 24 weeks that was not prevented by preservation with lec-SOD.
CONCLUSIONS: These results demonstrate that ischemia/reperfusion injury, apoptotic cell death and allo-immune responses may be exacerbated by cold ischemia and accelerate the development of CAF. Preservation with lec-SOD may protect against the early damage induced by cold ischemia and reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849471     DOI: 10.1046/j.1523-1755.2002.00217.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  The pharmacokinetics and effects of a long-acting preparation of superoxide dismutase (PC-SOD) in man.

Authors:  F J F Broeyer; B E van Aken; J Suzuki; M J B Kemme; H C Schoemaker; A F Cohen; Y Mizushima; J Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2007-07-04       Impact factor: 4.335

2.  Evaluation of lecithinized human recombinant super oxide dismutase as cardioprotectant in anthracycline-treated breast cancer patients.

Authors:  Frederik J F Broeyer; Susanne Osanto; Jun Suzuki; Felix de Jongh; Henk van Slooten; Bea C Tanis; Tobias Bruning; Jeroen J Bax; Henk J Ritsema van Eck; Marieke L de Kam; Adam F Cohen; Yutaka Mituzhima; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

3.  Preservation Solutions for Kidney Transplantation: History, Advances and Mechanisms.

Authors:  Yimeng Chen; Jian Shi; Terry C Xia; Renfang Xu; Xiaozhou He; Ying Xia
Journal:  Cell Transplant       Date:  2019-08-26       Impact factor: 4.064

4.  Adipose stem cell secretome markedly improves rodent heart and human induced pluripotent stem cell-derived cardiomyocyte recovery from cardioplegic transport solution exposure.

Authors:  Bradley W Ellis; Dmitry O Traktuev; Stephanie Merfeld-Clauss; Uryan Isik Can; Meijing Wang; Ray Bergeron; Pinar Zorlutuna; Keith L March
Journal:  Stem Cells       Date:  2020-12-23       Impact factor: 6.277

Review 5.  Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19?

Authors:  Ilaria Farella; Raffaella Panza; Manuela Capozza; Nicola Laforgia
Journal:  Biomed Pharmacother       Date:  2021-07-14       Impact factor: 6.529

Review 6.  The Effect of Antioxidant Added to Preservation Solution on the Protection of Kidneys before Transplantation.

Authors:  Aneta Ostróżka-Cieślik
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.